These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22297581)

  • 1. Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway.
    Sørgjerd EP; Skorpen F; Kvaløy K; Midthjell K; Grill V
    Diabetologia; 2012 May; 55(5):1310-8. PubMed ID: 22297581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.
    Zhou Z; Xiang Y; Ji L; Jia W; Ning G; Huang G; Yang L; Lin J; Liu Z; Hagopian WA; Leslie RD;
    Diabetes; 2013 Feb; 62(2):543-50. PubMed ID: 23086039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
    Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
    Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.
    Sørgjerd EP; Skorpen F; Kvaløy K; Midthjell K; Grill V
    Autoimmunity; 2013 Feb; 46(1):74-9. PubMed ID: 23061550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
    Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
    Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.
    Huang G; Yin M; Xiang Y; Li X; Shen W; Luo S; Lin J; Xie Z; Zheng P; Zhou Z
    Diabetes Metab Res Rev; 2016 Sep; 32(6):615-22. PubMed ID: 26787598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trøndelag Health (HUNT) study.
    Radtke MA; Midthjell K; Nilsen TI; Grill V
    Diabetes Care; 2009 Feb; 32(2):245-50. PubMed ID: 19001190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 Diabetes-related Autoantibodies in Different Forms of Diabetes.
    Sørgjerd EP
    Curr Diabetes Rev; 2019; 15(3):199-204. PubMed ID: 30058495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus.
    Huang G; Xiang Y; Pan L; Li X; Luo S; Zhou Z
    Diabetes Metab Res Rev; 2013 Jul; 29(5):363-8. PubMed ID: 23390067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune diabetes in adults: lessons from the UKPDS.
    Desai M; Clark A
    Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered natural killer (NK) cell frequency and phenotype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency.
    Akesson C; Uvebrant K; Oderup C; Lynch K; Harris RA; Lernmark A; Agardh CD; Cilio CM
    Clin Exp Immunol; 2010 Jul; 161(1):48-56. PubMed ID: 20408863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults.
    Jin P; Huang G; Lin J; Yang L; Xiang B; Zhou W; Zhou Z
    Clin Endocrinol (Oxf); 2011 May; 74(5):587-92. PubMed ID: 21470281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Ito Y; Hanafusa T
    J Diabetes Investig; 2020 Sep; 11(5):1181-1187. PubMed ID: 32175683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes.
    Andersen MK; Härkönen T; Forsblom C; Groop PH; Knip M; Tuomi T
    Autoimmunity; 2013 Jun; 46(4):251-8. PubMed ID: 23194113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.
    Hawa MI; Kolb H; Schloot N; Beyan H; Paschou SA; Buzzetti R; Mauricio D; De Leiva A; Yderstraede K; Beck-Neilsen H; Tuomilehto J; Sarti C; Thivolet C; Hadden D; Hunter S; Schernthaner G; Scherbaum WA; Williams R; Brophy S; Pozzilli P; Leslie RD;
    Diabetes Care; 2013 Apr; 36(4):908-13. PubMed ID: 23248199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11.
    Schloot NC; Pham MN; Hawa MI; Pozzilli P; Scherbaum WA; Schott M; Kolb H; Hunter S; Schernthaner G; Thivolet C; Seissler J; Leslie RD;
    Diabetes Care; 2016 Nov; 39(11):1932-1939. PubMed ID: 27573939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Latent autoimmune diabetes of adults (LADA): The informative value of autoantibodies].
    Silko YV; Nikonova TV; Ivanova ON; Stepanova SM; Shestakova MV; Dedov II
    Ter Arkh; 2016; 88(10):42-45. PubMed ID: 27801418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
    Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
    Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.